And this well-organized trial ended early, before reaching the hoped-for number of enrolled patients, for a reason that may seem, to those of us in the rest of the world, enviable and weird: Wuhan ran out of Covid patients. The strict lockdown of that city, the testing and tracing and isolating, all the nonpharmaceutical interventions, had made pharmaceutical interventions unnecessary. On the day that the Wuhan remdesivir study was published, April 29, 2020, China at large had a total of four new cases and no new deaths.
